Asia Pacific Dementia Treatment Market, 2026-2033
Global Market
Related Markets
Asia Pacific dementia treatment market highlights
- The Asia Pacific dementia treatment market generated a revenue of USD 4,446.2 million in 2025.
- The market is expected to grow at a CAGR of 9% from 2026 to 2033.
- In terms of segment, alzheimer’s disease dementia was the largest revenue generating indication in 2025.
- Lewy Body Dementia is the most lucrative indication segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 4,446.2 million |
| Market revenue in 2033 | USD 8,783.3 million |
| Growth rate | 9% (CAGR from 2026 to 2033) |
| Largest segment | Alzheimer’s disease dementia |
| Fastest growing segment | Lewy Body Dementia |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Parkinson Disease Dementia, Vascular Dementia, Alzheimer’s Disease Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Other Indications |
| Key market players worldwide | Eisai Co Ltd, Eli Lilly and Co, Novartis AG ADR, Daiichi Sankyo Co Ltd, AbbVie Inc, H. Lundbeck AS Class A, Biogen Inc, Cipla Ltd DR, Sun Pharmaceutical Industries, Viatris Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 23.3% of the global dementia treatment market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,783.3 million by 2033.
Asia Pacific dementia treatment market is expected to register the fastest CAGR of 9.5% in the forecast period. The presence of a large target population, high unmet clinical needs, and developing healthcare is anticipated to provide high growth potential for the regional market.
It is expected that more than 75% of Alzheimer’s disease and related dementias to occur in low- and middle-income countries by 2050. Developing countries, such as China and India, have a large patient base with high unmet medical needs that create market opportunities for key players in the region.
No credit card required*
Publish Date: Jun 12, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Dementia Treatment Market Report
Dementia Treatment Market Report Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Cipla Ltd DR | View profile | 38,955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | www.cipla.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | www.sunpharma.com |
| Eli Lilly and Co | View profile | 43,000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | www.lilly.com |
| Biogen Inc | View profile | 7,570 | 225 Binney Street, Cambridge, MA, United States, 02142 | www.biogen.com |
| Viatris Inc | View profile | 38,000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | www.viatris.com |
| Daiichi Sankyo Co Ltd | View profile | 17,435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | www.daiichisankyo.com |
| Eisai Co Ltd | View profile | 11,076 | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 | www.eisai.co.jp |
| H. Lundbeck AS Class A | View profile | 5,700 | Ottiliavej 9, Valby, Denmark, 2500 | www.lundbeck.com |
Asia Pacific dementia treatment market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Dementia Treatment Market will help companies and investors design strategic landscapes.
Alzheimer’S Disease Dementia was the largest segment with a revenue share of 63.98% in 2025.
Horizon Databook has segmented the Asia Pacific dementia treatment market based on parkinson disease dementia, vascular dementia, alzheimer’s disease dementia, lewy body dementia, frontotemporal dementia (ftd), other indications covering the revenue growth of each sub-segment from 2021 to 2033.
Asia Pacific dementia treatment market is expected to register the fastest CAGR of 9.5% in the forecast period. The presence of a large target population, high unmet clinical needs, and developing healthcare is anticipated to provide high growth potential for the regional market.
It is expected that more than 75% of Alzheimer’s disease and related dementias to occur in low- and middle-income countries by 2050. Developing countries, such as China and India, have a large patient base with high unmet medical needs that create market opportunities for key players in the region.
- Asia Pacific Dementia Treatment Market Indication Outlook (Revenue, USD Million , 2021-2033)
- Alzheimer’s Disease Dementia
- Vascular Dementia
- Lewy Body Dementia
- Frontotemporal Dementia (FTD)
- Parkinson Disease Dementia
- Other Indications
- Asia Pacific Dementia Treatment Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
- Cholinesterase Inhibitors
- NMDA Receptor Antagonist
- MAO Inhibitors
- Combination Drug
- Other Drug Classes
- Asia Pacific Dementia Treatment Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Oral
- Transdermal Patch
- Injectable
- Asia Pacific Dementia Treatment Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Reasons to subscribe to dementia treatment market report databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of dementia treatment market report databook
- Our clientele includes a mix of dementia treatment market report companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific dementia treatment market report, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific dementia treatment market report from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Dementia Treatment Market, 2021-2033 (US$M)
Asia Pacific Indication - Dementia Treatment Market, 2025 - 2033 (US$M)
